PTCT

PTC THERAPEUTICS, INC.

NasdaqHealthcarePharmaceutical Preparations

Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingAug 28, 2026Most recent Form 4
Total buying$00 buys
Total selling$381M11 sells
Net open-market-$381M2 insiders
Open-market mix
Buy vs sell distribution by transaction count
11 transactions
0 buys0%·100%11 sells

Insider activity report

Monthly open-market purchase and sale counts
Buys Sells
1580-8-15transactionsAug 2026 sells: 11 transactions · $381M11AugSep

Transaction codes

By Form 4 transaction code in selected period
13transactions
  • S · Open-market sells · dominant11 · 85%
  • M · Option exercise2 · 15%

Activity by reported role

A joint filing can contribute to multiple roles
13transactions
  • Director · dominant9 · 69%
  • EVC4 · 31%

Distinct insiders active

Reporting-owner CIKs by month · peak Aug 2026 (2)
Aug 2026Sep 2026
2distinct insiders in 2 months

Reported Holdings After

Separated by insider, security, and ownership type
Schmertzler MichaelCommon Stock · Indirect · See footnote
1.4M1.3MAug 19, 2026 · 1,381,259 shares owned afterAug 19, 2026 · 1,374,094 shares owned afterAug 20, 2026 · 1,361,594 shares owned afterAug 20, 2026 · 1,364,675 shares owned afterAug 20, 2026 · 1,362,285 shares owned afterAug 26, 2026 · 1,349,094 shares owned afterAug 26, 2026 · 1,354,720 shares owned afterAug 27, 2026 · 1,337,204 shares owned afterAug 27, 2026 · 1,336,594 shares owned afterAug 19, 2026Aug 27, 2026
1,336,594Aug 27, 2026
Boulding Mark ElliottCommon Stock · Direct
108.1k105.3kAug 17, 2026 · 108,085 shares owned afterAug 17, 2026 · 106,241 shares owned afterAug 17, 2026 · 105,272 shares owned afterAug 17, 2026Aug 17, 2026
105,272Aug 17, 2026
Boulding Mark ElliottStock Option (Right to Buy) · Direct
16.9k16.9kAug 17, 2026 · 16,876 shares owned afterAug 17, 2026Aug 17, 2026
16,876Aug 17, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
0 active days
Aug 04Sep 04
LessMore

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale$85.0M
10b5-1 detected13
Amended rows0

PTCT transaction history

Filters apply within this company and selected period by default
Reset
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date

No transactions match your filters

Once the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range.

PTC THERAPEUTICS, INC. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at PTC THERAPEUTICS, INC.?

SCHMERTZLER MICHAEL, Boulding Mark Elliott.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Schmertzler Michael reported a sale on Aug 27, 2026 valued at $4.40M. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $3,816,047.79. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.